New drugs in non-small cell lung cancer. An overview

G Giaccone1

  • 1Free University Hospital, Department of Oncology, Amsterdam, The Netherlands.

Insights

Chemotherapy for non-small cell lung cancer shows limited effectiveness. However, novel agents like taxanes and CPT-11 offer new treatment strategies with demonstrated activity against this disease.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Chemotherapy demonstrates limited efficacy in treating non-small cell lung cancer (NSCLC).
  • Advancements in understanding NSCLC biology are crucial for developing effective therapies.

Purpose of the Study:

  • To review recent developments in anticancer agents for NSCLC.
  • To highlight novel drugs with demonstrated activity in NSCLC treatment.

Main Methods:

  • Literature review of recent clinical studies and drug development in NSCLC.
  • Analysis of novel anticancer agents including taxanes, CPT-11, antimetabolites (edatrexate, gemcitabine), and vinorelbine.

Main Results:

  • Several new anticancer agents exhibit significant activity in NSCLC.
  • Taxanes, CPT-11, edatrexate, gemcitabine, and vinorelbine represent promising therapeutic options.

Conclusions:

  • Novel agents are improving treatment outcomes for non-small cell lung cancer.
  • Further research into lung cancer biology will drive future treatment innovations.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...